Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

Omega-3 Levels Affect Whether B Vitamins Can Slow Brain's Decline

January 20, 2016 7:15 am | by University of Oxford | News | Comments

An international team have now found that having higher levels of Omega-3 fatty acids in your body could boost the B vitamins' effect. Read more...

TOPICS:

Parkinson's Disease Treatment Pipeline Shows Promise for Patients, Investors

January 20, 2016 7:00 am | by Angel Wong, Senior Analyst, GBI Research | News | Comments

The Parkinson’s disease treatment pipeline presents a distinctly more promising landscape than the current market. Read more...

TOPICS:

NIH Genome Sequencing Program Targets the Genomic Bases of Common, Rare Disease

January 19, 2016 11:44 am | by National Institutes of Health (NIH) | News | Comments

The National Institutes of Health will fund a set of genome sequencing and analysis centers whose research will focus on understanding the genomic bases of common and rare human diseases. Read more...

TOPICS:
Advertisement

Study Quantifies Faulty Gene's Role in Ovarian Cancer Risk

January 19, 2016 11:36 am | News | Comments

Women who carry an inherited fault in the BRIP1 gene are three times more likely to develop ovarian cancer than those without it, researchers said Tuesday. The gene variant had already been linked to cancer of the ovaries, but the size of the additional risk has now been quantified in a study in the Journal of the National Cancer Institute. Read more...

TOPICS:

Scientists Take Steps to Make Weak TB Drugs Strong Again

January 19, 2016 11:12 am | by Johns Hopkins | News | Comments

Biophysicists have discovered why the bacteria that cause tuberculosis (TB) are naturally somewhat resistant to antibiotics known as fluoroquinolones. Their findings, based on mapping the detailed three-dimensional structure of the drugs interacting with an essential enzyme in the TB germ, also reveal why some TB drugs are more potent than others. Read more...

TOPICS:

J&J to Cut 3,000 Jobs in Struggling Medical Device Division

January 19, 2016 10:49 am | by Reuters | News | Comments

Johnson & Johnson said on Tuesday it would cut about 3,000 jobs within its medical devices unit over the next two years, or about 4 to 6 percent of the struggling division's global workforce, to generate annual cost savings of up to $1 billion and focus on more innovative products. Read more...

TOPICS:

Accelerating Drug Discovery Through Data Analysis

January 19, 2016 10:00 am | by Ryan Bushey, Associate Editor | Articles | Comments

Clinical research can be a risky and laborious process, but this startup could solve that problem. Read more...

TOPICS:

Effort to Curb Overuse of Antibiotics Amid Cold, Flu Seasons

January 19, 2016 9:24 am | by Lauren Neergaard, AP Medical Writer | News | Comments

It's cold season, and the miserable continue to trudge in, seeking antibiotics because of mucus turned green, or a cough that has nagged for weeks. Despite years of warnings, doctors still overprescribe antibiotics for acute respiratory infections even though most are caused by viruses that those drugs cannot help. Read more...

TOPICS:
Advertisement

Failed French Drug Trial Hospitalizes Six Participants

January 19, 2016 8:22 am | by Ryan Bushey, Associate Editor | News | Comments

Health Minister Marisol Touraine said all six volunteers were healthy before they took part in the study. Read more...

TOPICS:

RSV Treatment Market Will Surpass $2.3B by 2024

January 19, 2016 8:22 am | by Christopher J. Pace, Ph.D., GlobalData’s Director of Infectious Diseases | News | Comments

Synagis (palivizumab) is the only licensed product indicated for the prevention of RSV in infants at a high risk of severe infection. Read more...

TOPICS:

India's Wockhardt Slumps after FDA Criticisms of New Drug Plant

January 19, 2016 8:00 am | by Zeba Siddiqui, Reuters | News | Comments

Indian drugmaker Wockhardt said the FDA had issued a notice outlining manufacturing violations at its Shendra plant in western India. Read more..

A Drug Deal Gone Bad

January 19, 2016 7:45 am | by Stephen Witt, New York Magazine | News | Comments

Toward the end of 2014, Russell Reitz, a genial Southern California pharmacist and serial entrepreneur. Read more...

TOPICS:

New Ebola Case Emerges in Sierra Leone

January 19, 2016 7:30 am | by Clarence Roy-Macaulay, Associated Press | News | Comments

A woman who died this week in Sierra Leone tested positive for Ebola, officials said Friday. Read more...

TOPICS:

Patient Involvement Could Improve Medicines R&D, Industry Personnel Suggest

January 19, 2016 7:15 am | by University of Manchester | News | Comments

Patients have become increasingly involved in managing their own health over recent years. Read more...

TOPICS:

Study Finds How Diabetes Drug Metformin Inhibits Progression of Pancreatic Cancer

January 15, 2016 10:03 am | by Massachusetts General Hospital | News | Comments

Massachusetts General Hospital (MGH) investigators may have uncovered a novel mechanism behind the ability of the diabetes drug metformin to inhibit the progression of pancreatic cancer. In their report that has been published in the open access journal PLOS One, the research team describes finding that metformin decreases the inflammation and fibrosis characteristic of the most common form of pancreatic cancer. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading